Snapshot

Why Jeedimetla is iconic:
Jeedimetla, part of Hyderabad’s industrial belt, is India’s first and oldest pharma manufacturing hub, established in the 1970s as a bulk drug park. Today, it hosts a diverse ecosystem of pharma formulations, APIs, intermediates, and biotech R&D centers. Jeedimetla is considered the backbone of Hyderabad’s “Genome Valley” pharma ecosystem, supporting global exports of generics, OTC drugs, and bulk intermediates.

Industrial edge:

• Houses legacy manufacturing units of major Indian pharma giants like Dr. Reddy’s, Aurobindo, and Hetero.
  
• End-to-end value chain: API synthesis, intermediates, formulation plants, R&D, and packaging.
  
• Strategically connected to Genome Valley (R&D) and ports, offering low-cost, export-ready capabilities.
  

Scale: Over 200+ pharma units, including USFDA, EMA, WHO GMP-certified plants, making it a reliable global supply base.

Product Range

Category	Key Products
APIs (Bulk Drugs)	Anti-infectives, cardiovascular, oncology, anti-retroviral APIs
Finished Formulations	Tablets, capsules, syrups, ointments, injectables
Intermediates & KSMs	Key starting materials for global pharmaceutical supply chains
OTC & Nutraceuticals	Multivitamins, supplements, protein powders
Specialty Drugs	Controlled substances, orphan drugs (limited units)
Contract Manufacturing (CDMO)	Formulation and API contract manufacturing for global brands

Cluster Strengths

Feature	Details
India’s Oldest Pharma Hub	Established as a bulk drug park in the 1970s
Regulatory-Approved Facilities	USFDA, EMA, WHO GMP-certified API & formulation plants
End-to-End Pharma Ecosystem	API synthesis, formulation, intermediates, packaging, logistics
Skilled Workforce	Access to Hyderabad’s pharma universities and R&D talent
Legacy & Emerging Pharma Leaders	Aurobindo, Dr. Reddy’s, Hetero, MSN Labs, Granules India
Strategic Location	Linked to Genome Valley R&D zone, Shamshabad Airport, and seaports (Chennai, Krishnapatnam, Kakinada)

Materials & Sustainability

Key Materials: API raw chemicals, solvents, excipients, drug delivery systems, capsules, blister packaging materials.

Sustainability Edge:

• Common Effluent Treatment Plants (CETPs) with strict CPCB & GPCB compliance
  
• ZLD (Zero Liquid Discharge) implementation for major API producers
  
• Solar and green power adoption in SEZ units
  
• Waste recycling initiatives for solvents and packaging materials
  

Cluster Infrastructure

• Industrial Areas: Jeedimetla Industrial Estate, Bachupally Pharma Zone, Genome Valley proximity
  
• Institutions:
  
  • National Institute of Pharmaceutical Education & Research (NIPER) – Hyderabad
    
  • Indian Institute of Chemical Technology (IICT)
    
  • Pharmexcil (Pharmaceutical Export Promotion Council) headquarters
    
• Connectivity:
  
  • Shamshabad International Airport (~45 km) for pharma cargo
    
  • Road network to Krishnapatnam, Kakinada, Chennai Ports
    
  • ICD Sanathnagar and Hyderabad for container exports
    

Compliance & Certifications

• USFDA, EMA, WHO GMP, MHRA, TGA certifications for APIs and formulations
  
• ICH Q7 and Q10 compliance for API synthesis
  
• ISO 9001, ISO 14001, OHSAS 18001-certified facilities
  
• DMF filings for global regulated markets
  
• CDSCO/DCGI approvals for domestic manufacturing
  

Production Timelines & MOQs

Product Type	Sampling Lead Time	Bulk Lead Time	MOQ Guidance
APIs & Bulk Drugs	2–3 weeks	6–8 weeks	100–500 kg per API
Formulations (Tablets/Capsules)	2 weeks	5–7 weeks	500,000–1M tablets per SKU
Injectables	3–4 weeks	8–10 weeks	100,000+ vials
OTC/Nutraceuticals	2 weeks	4–6 weeks	50,000+ bottles/cartons
Custom Manufacturing (CDMO)	3–4 weeks (dev)	8–12 weeks	Project-based

Branding & Packaging

• Branding: QR-coded blister packs, serialization (Track & Trace), private-label packaging
  
• Packaging:
  
  • HDPE bottles, alu-alu blisters, blister cartons, bulk drums
    
  • Temperature-controlled secondary packaging for export
    
  • Serialization-ready lines (US DSCSA, EU FMD compliance)
    

Quality Control (IndiaUnbox Protocol)

• NABL-accredited QC labs with HPLC, GC-MS, and LC-MS/MS
  
• In-process control (IPC) checks per ICH guidelines
  
• Stability studies under WHO and ICH climatic zones
  
• Microbial and sterility testing for injectables
  
• Export QC: Third-party audits (SGS, Bureau Veritas, TUV)
  

Price Drivers

• Cost of solvents and imported intermediates
  
• Regulatory filing costs (DMF, ANDA, CEPs) for global supply
  
• Energy and ETP/CETP operating expenses for ZLD compliance
  
• Packaging (serialization, tamper-proofing) and cold-chain logistics
  
• PLI and Telangana incentives reducing net manufacturing cost
  

Buyer Confidence Signals

• Jeedimetla is India’s legacy pharma hub, contributing to India’s rise as the “Pharmacy of the World”.
  
• Cluster houses top Indian generics exporters like Dr. Reddy’s, Aurobindo, Hetero, Granules India.
  
• Supported by Pharmexcil and Telangana Government’s Pharma Policy.
  
• Proven compliance track record with regulated markets (US, EU, Japan, WHO).
  

Ideal for buyers seeking cost-efficient APIs, high-volume generics, and CDMO partnerships